RxDoctor Payments Data

Pradeep Gnanapragasam, MD

Physical Medicine & Rehabilitation · Lafayette, INNPI 1750677589

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 51.9% of the total.

$830in general payments, 2019–2025

Across 14 payments — averaging $59.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$431
  • Merz Pharmaceuticals, LLC$201
  • Inari Medical, Inc.$132
  • Saol Therapeutics Inc.$22
  • Grifols USA, LLC$20
  • Avanir Pharmaceuticals, Inc.$13
  • plus $12 from 1 others

What the payments were for

  • Food & beverage$830100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)6$431
Merz Pharmaceuticals, LLC3$201
Inari Medical, Inc.1$132
Saol Therapeutics Inc.1$22
Grifols USA, LLC1$20
Avanir Pharmaceuticals, Inc.1$13
AstraZeneca1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$830 in reported general payments places this provider in the 60th percentile of 140 physical medicine & rehabilitation providers in Indiana.

See all physical medicine & rehabilitation providers in Indiana

Medicare billing

Part B allowed, 2024
$166,731
Medicare patients
201
Services billed
7,962

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$9,610
Tizanidine Hcl14$3,330
Dantrolene Sodium25$2,681
Baclofen49$937
Methylphenidate Hcl16$307
Gabapentin23$303
Trazodone Hcl39$250
Amitriptyline Hcl19$218
Atorvastatin Calcium22$185
Ropinirole Hcl17$178
Pantoprazole Sodium27$166
Oxybutynin Chloride ErOxybutynin Chloride17$117
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$61
Amiodarone Hcl14$53
Zolpidem Tartrate12$21

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Lafayette

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →